Print Page | Close Window

Corporate Profile

Gilead Sciences is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. The company's mission is to advance the care of patients suffering from life-threatening diseases worldwide. Gilead has operations in more than 30 countries worldwide, with headquarters in Foster City, California.

Recent Press Releases

July 03, 2015 - 2:01 a.m.
Japan’s Ministry of Health, Labour and Welfare Approves Gilead’s Harvoni®, the First Once-Daily Single Tablet Regimen for the Treatment of Genotype 1 Chronic Hepatitis CPrinter Friendly Version 
July 01, 2015 - 4:30 p.m.
Gilead Submits New Drug Application to U.S. Food and Drug Administration for Single Tablet Regimen for HIV Containing Rilpivirine, Emtricitabine and Tenofovir Alafenamide (R/F/TAF)Printer Friendly Version 

Upcoming Events

Sunday, July 19, 2015 through Wednesday, July 22, 2015
8th IAS Conference on HIV Pathogenesis, Treatment and Prevention
LocationVancouver, Canada

Most Viewed Links

Updated 07/04/15
1.SEC Filings
2.Earnings
3.Stock Information
4.Annual Reports
5.Fundamentals - Snapshot
* Data collected 06/26/15 - 07/03/15

Replication or redistribution of EDGAR Online, Inc. content is expressly prohibited without the prior written consent of EDGAR Online, Inc. EDGAR Online, Inc. shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.